SCHEMBL489381

SCHEMBL489381

C[C@H](O)[C@H](O)[C@](C)(O)CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29257444 1.00
SCHEMBL22748732 1.00
SCHEMBL7153761 1.00
SCHEMBL27832365 0.83
SCHEMBL29367973 0.80
SCHEMBL1782900 0.78
SCHEMBL14151245 0.76
SCHEMBL29519762 0.76
SCHEMBL7095495 0.76
SCHEMBL1784351 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 937 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127642-A1 SELECTIVE VALORIZATION OF BIOMASS SUGARS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-06-24 WO claimed
EP-3423066-A1 GLYCOALKALOID COMBINATIONS AND VARIOUS USES THEREOF Cham, Bill Elliot (VU) 2019-01-09 EP claimed
EP-3328439-A1 MULTILIGAND AGENT FOR DRUG DELIVERY Arcturus Therapeutics, Inc. (US) 2018-06-06 EP claimed
US-20180148434-A1 Novel 16-member triamilide derivatives and uses thereof VICTOR PHARMA CO., LTD. ZHENJIANG (CN) 2018-05-31 US claimed
WO-2017023817-A1 MULTILIGAND AGENT FOR DRUG DELIVERY ARCTURUS THERAPEUTICS, INC. (US) 2017-02-09 WO claimed
EP-1091971-B1 POLYKETIDE SYNTHESIS BIOTICA TECH LTD (GB) 2010-03-17 EP claimed
EP-1278881-B1 HYBRID GLYCOSYLATED PRODUCTS AND THEIR PRODUCTION AND USE BIOTICA TECH LTD (GB) 2009-12-30 EP claimed
WO-2009110938-A9 NOVEL MACROCYCLIC POLYENE LACTAMS NOVOBIOTIC PHARMACEUTICALS LLC (US) 2009-12-17 WO claimed
WO-2009110938-A2 NOVEL MACROCYCLIC POLYENE LACTAMS NOVOBIOTIC PHARMACEUTICALS LLC (US) 2009-09-11 WO claimed
US-7538092-B2 Pharmaceutically active oligosaccharide conjugates FRESENIUS KABI DEUTSCHLAND GMBH (DE) 2009-05-26 US claimed
EP-0288897-B1 ENKASTINES: GLYCOPEPTIDES WITH AN ENKEPHALINASE-INHIBITING EFFECT, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE HOECHST AKTIENGESELLSCHAFT (DE) 1993-08-11 EP claimed
EP-0515386-A1 GLYCOALKALOIDS CURA NOMINEES PTY LTD (AU) 1992-12-02 EP claimed
US-5114930-A Anthelmintics MERCK & CO., INC. (US) 1992-05-19 US claimed
EP-0457517-A1 Avermectin derivatives with a spacer inserted between the disaccharide and the aglycone useful as antiparastic agents MERCK & CO. INC. (US) 1991-11-21 EP claimed
WO-1991010743-A1 GLYCOALKALOIDS CURA NOMINEES PTY LTD (AU) 1991-07-25 WO claimed
EP-0292352-A2 Macrolide derivatives, process for their preparation and their pharmaceutical compositions ADIR ET COMPAGNIE (FR) 1988-11-23 EP claimed
EP-0103465-B1 20-AMINO MACROLIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1986-09-10 EP claimed
EP-0087921-B1 20-AMINO TYLOSIN DERIVATIVES Omura, Satoshi (JP) 1985-10-09 EP claimed
EP-0103465-A1 20-Amino macrolide derivatives ELI LILLY AND COMPANY (US) 1984-03-21 EP claimed
EP-0087921-A1 20-Amino tylosin derivatives Omura, Satoshi (JP) 1983-09-07 EP claimed